Collecting tissue samples from patients with various gastrointestinal cancers
Official title: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Run by University of Chicago · NCT01416714 · Data updated 2026-11-12
This study is collecting tissue and blood samples from patients with different gastrointestinal cancers to help researchers learn more about these diseases.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | July 2, 2008 |
| Main results expected | January 2030 |
| Study ends | January 2030 |
| Registry record updated | October 1, 2025 |
| Trial ID | NCT01416714 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with any of the specified gastrointestinal cancers who are undergoing surgery or a biopsy.
✕Probably not a fit
Patients with cancers not specified in the study or those not undergoing surgical or diagnostic procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to collect and store both normal and malignant tissue samples from patients diagnosed with several types of gastrointestinal cancers, including gastric cancer, esophageal cancer, and colorectal cancer, among others. It will also gather blood samples from these patients to create a comprehensive database that includes relevant clinical information. The collected samples will be used to create tissue microarrays for each cancer subtype, facilitating future molecular studies and enhancing our understanding of these diseases.
Why it matters
Potential benefit: If successful, this study could significantly advance research into gastrointestinal cancers and improve future treatment strategies.
How similar studies have gone: Other studies involving tissue procurement for cancer research have shown success in advancing our understanding of various malignancies, indicating that this approach is both valuable and tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * any patient diagnosed with Gastric (stomach) Cancer, Esophageal (foodpipe) Cancer, Pancreas Cancer, Liver Cancer, Biliary (gallbladder) Cancer, Gastrointestinal Stromal Tumor, Peritoneal Mesothelioma (cancer in the lining of the abdomen), Neuroendocrine (of or relating to the cells that release a hormone into the blood in response to a neural stimulus) Tumor, Anal Cancer or Colorectal Cancer cancer that requires you to undergo a surgical or diagnostic procedure.
Where it's running
-
The University of Chicago
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Daniel Catenacci, MD — University of Chicago
- Study coordinator: Daniel Catenacci, MD
- Email: dcatenac@medicine.bsd.uchicago.edu
- Phone: 773-702-7596
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gastric Cancer Clinicobiological Cohort Study
This study tests the tumor microenvironment in gastric and gastroesophageal junction cancers from patients who had surgery after standard neoadjuvant chemotherapy at a single center.
-
GEH300079 (68Ga) PET/CT scan to detect peritoneal carcinomatosis in colorectal, gastric, ovarian, and pancreatic cancers (PERISCOPE)
This will test whether a GEH300079 (68Ga) PET/CT scan can detect peritoneal carcinomatosis in adults with colorectal, gastric, ovarian, or pancreatic ductal adenocarcinoma who have known or suspected peritoneal disease.
-
Link between psychological distress and immune therapy response in gastric cancer
We will see if psychological distress influences how well immune checkpoint inhibitors work in adults with gastric adenocarcinoma receiving preoperative immunotherapy before surgery.
-
Robotic removal of stomach tumors after pre-surgery chemotherapy for advanced gastric cancer
This trial tests whether robotic stomach cancer surgery after 3–4 cycles of preoperative therapy is safe and helps people with stage III resectable gastric or gastroesophageal junction adenocarcinoma.
-
Using deep learning and Raman spectroscopy for early cancer diagnosis
This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.
-
QL1706 combined with SOX for treating advanced gastric cancers
This study is testing if a new treatment combining QL1706 and SOX can help people with advanced stomach cancer before surgery and improve their chances of recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.